207 related articles for article (PubMed ID: 34144374)
1. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: Decontamination therapy in allo-HCT.
Gałązka P; Styczyński J; Czyżewski K; Salamonowicz-Bodzioch M; Frączkiewicz J; Zając-Spychała O; Zaucha-Prażmo A; Goździk J; Biliński J; Basak GW
Curr Res Transl Med; 2021 Jul; 69(3):103298. PubMed ID: 34144374
[TBL] [Abstract][Full Text] [Related]
2. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
3. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
Daoud-Asfour H; Henig I; Ghersin I; Rakedzon S; Stern A; Pitashny M; Zuckerman T; Bar-Yoseph H
Transplant Cell Ther; 2022 Mar; 28(3):168.e1-168.e8. PubMed ID: 34954293
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group.
Piekarska A; Sadowska-Klasa A; Mensah-Glanowska P; Sobczyk-Kruszelnicka M; Drozd-Sokołowska J; Waszczuk-Gajda A; Kujawska J; Wilk M; Tomaszewska A; Zaucha JM; Giebel S; Gil L
Sci Rep; 2024 Mar; 14(1):5947. PubMed ID: 38467719
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
[TBL] [Abstract][Full Text] [Related]
6. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
7. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
8. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
[TBL] [Abstract][Full Text] [Related]
9. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation.
Sadowska-Klasa A; Piekarska A; Prejzner W; Bieniaszewska M; Hellmann A
Ann Hematol; 2018 Mar; 97(3):509-517. PubMed ID: 29255911
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study.
Ito A; Kim SW; Matsuoka KI; Kawakita T; Tanaka T; Inamoto Y; Toubai T; Fujiwara SI; Fukaya M; Kondo T; Sugita J; Nara M; Katsuoka Y; Imai Y; Nakazawa H; Kawashima I; Sakai R; Ishii A; Onizuka M; Takemura T; Terakura S; Iida H; Nakamae M; Higuchi K; Tamura S; Yoshioka S; Togitani K; Kawano N; Suzuki R; Suzumiya J; Izutsu K; Teshima T; Fukuda T
Int J Hematol; 2020 Nov; 112(5):674-689. PubMed ID: 32748216
[TBL] [Abstract][Full Text] [Related]
11. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
12. Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Reshef R; Ganetsky A; Acosta EP; Blauser R; Crisalli L; McGraw J; Frey NV; Hexner EO; Hoxie JA; Loren AW; Luger SM; Mangan J; Stadtmauer EA; Mick R; Vonderheide RH; Porter DL
Biol Blood Marrow Transplant; 2019 Mar; 25(3):515-521. PubMed ID: 30315941
[TBL] [Abstract][Full Text] [Related]
13. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. [Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
de Berranger E; Charbonnier A; Davy E; Dendonker C; Denis V; Desmier D; Farrugia C; Guenounou S; Guilbert Y; Jost E; L'hostette A; Rialland F; Taque S; Yafour N; Seguy D; Yakoub Agha I
Bull Cancer; 2021 Dec; 108(12S):S30-S38. PubMed ID: 33966887
[TBL] [Abstract][Full Text] [Related]
16. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
Hashimoto D; Chow A; Greter M; Saenger Y; Kwan WH; Leboeuf M; Ginhoux F; Ochando JC; Kunisaki Y; van Rooijen N; Liu C; Teshima T; Heeger PS; Stanley ER; Frenette PS; Merad M
J Exp Med; 2011 May; 208(5):1069-82. PubMed ID: 21536742
[TBL] [Abstract][Full Text] [Related]
18. Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient.
Maziarz RT; Devine S; Garrison LP; Agodoa I; Badaracco J; Gitlin M; Perales MA
Transplant Cell Ther; 2023 Oct; 29(10):637.e1-637.e9. PubMed ID: 37364775
[TBL] [Abstract][Full Text] [Related]
19. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis.
Gavriilaki M; Sakellari I; Anagnostopoulos A; Gavriilaki E
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1738-1746. PubMed ID: 32447043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
